Avanzando Caminos (Leading Pathways) Study

The Avanzando Caminos (Leading Pathways): Hispanic/Latino Cancer Survivorship Study is a six-year observational study that will enroll 3,000 Hispanic/Latino cancer survivors in South Texas and South Florida.

We want to understand the social, cultural, behavioral, mental, biological, and medical influences on the post-cancer life of the Hispanic/Latino community.

This study is funded by the National Cancer Institute and is affiliated with the University of Miami Sylvester Comprehensive Cancer Center and the University of Texas at San Antonio Mays Cancer Center. 

To find out if you're eligible to participate in this study, please fill out the pre-qualification form below, and someone from our team will contact you.

Be a Part of History

We’re looking for volunteers to join our study! Volunteers like you can help future generations of Hispanic/Latino cancer survivors.

Representation in Clinical Cohort Studies Matters

So, why are we targeting Hispanic/Latino cancer survivors?

Did you know that the leading cause of death among Hispanics and Latinos in the US is cancer? For years, this community has been underrepresented in clinical research and more adversely affected by cancer. These communities must be prioritized in clinical studies so that we can work to improve their survivorship experiences.

Who Can Join?

We are building the first-of-its-kind, national cohort of Hispanic/Latino cancer survivors. As we all know, the Hispanic/Latino community is not monolithic. Both South Florida and South Texas make up a rich, diverse tapestry of people, including Cubans, South Americans, Central Americans, Puerto Ricans, Mexicans, and Mexican-Americans.

To enroll, you must meet the following criteria:

• Age: 18 years or older
• Able to read in English or Spanish
• Willing to attend study visits
• Completed primary treatment for breast, prostate, colon, kidney, liver, lung, stomach, cervical, endometrial, ovarian, thyroid, lymphomas (Non-Hodgkin and Hodgkin), bladder, or melanoma cancers within the past ten years
• No evidence of distant metastatic disease, or stage IV with No Evidence of Disease (NED) and or No Evidence of Disease Progression (NEDP) within the past year

San Antonio

To contact the San Antonio study coordinator, please call 210-562-6514 or email us at Caminos@uthscsa.edu.

Miami

To contact the Miami study coordinator, please call 305-243-7777 or email us at caminos@miami.edu. Read more about our studies offered at the University of Miami Miller School of Medicine here.